Abstract:Wei Xu, 1, &ast Zikai Zhang, 2, &ast Kerong Hu, 1, &ast Ping Fang, 1 Ran Li, 1 Dehong Kong, 1 Miao Xuan, 1 Yang Yue, 3 Dunmin She, 4, 5 Ying Xue 1 1 Department of Endocrinology and Metabolism, Tongji Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China; 2 Department of Oncology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China; 3 School of Mathematics and Statistics, University of Melbourne, Melbourne, Australia; 4 Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu, People's Republic of China; 5 Department of Endocrinology, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, Jiangsu, People's Republic of China &astThese authors contributed equally to this work Correspondence: Ying Xue, Department of Endocrinology and Metabolism, Tongji Hospital, School of Medicine, Tongji University, No. 389, Xincun Road, Shanghai, People's Republic of China, Tel +86-21-66111061, Email Dunmin She, Clinical Medical College, Yangzhou University, No. 98, Nantong West Road, Yangzhou, Jiangsu, People's Republic of China, Email Purpose: The objective of this study was to employ machine learning (ML) models utilizing non-invasive factors to achieve early and low-cost identification of MetS in a large physical examination population. Patients and Methods: The study enrolled 9171 participants who underwent physical examinations at Northern Jiangsu People's Hospital in 2009 and 2019, to determine MetS based on criteria established by the Chinese Diabetes Society. Non-invasive characteristics such as gender, age, body mass index (BMI), systolic blood pressure (SBP), and diastolic blood pressure (DBP) were collected and used as input variables to train and evaluate ML models for MetS identification. Several ML models were used for MetS identification, including logistic regression (LR), k-nearest neighbors algorithm (k-NN), naive bayesian (NB), decision tree (DT), random forest (RF), artificial neural network (ANN), and support vector machine (SVM). Results: Our ML models all showed good performance in the 10-fold cross-validation except for the SVM model. In the external validation, the NB model exhibited the best performance with an AUC of 0.976, accuracy of 0.923, sensitivity of 98.32%, and specificity of 91.32%. Conclusion: This study proposed a new non-invasive method for early and low-cost identification of MetS by using ML models. This approach has the potential to serve as a highly sensitive, convenient, and cost-effective tool for large-scale MetS screening. Keywords: metabolic syndrome, machine learning methods, non-invasive method, naive Bayesian Metabolic syndrome (MetS) refers to a set of combined metabolic disorders, including obesity, hypertension (HBP), hyperglycemia, and dyslipidemia such as elevated triglycerides (TG), and reduced high-density lipoprotein cholesterol (HDL-C), 1 which is one of the vital risk factors for accelerating progression of cardiovascular disease (CVD), 2 chronic kidney disease (CKD) 3 and type 2 diabetes (T2DM). 4–6 Several criteria defining MetS in adults have been established by expert panels from organizations such as the National Cholesterol Education Program's Adult Treatment Panel III (NCEP: ATP III), 4 the World Health Organization (WHO), 7 the European Group for the Study of Insulin Resistance, 8 the International Diabetes Federation (IDF) 1 and the Chinese Diabetes Society. 9 However, there is still no globally accepted definition of MetS. MetS is a growing global health concern, 10 with an estimated number of affected individuals exceeding one billion and continuing to rise. 11 In a study conducted in the United States, a weighted prevalence of MetS was found to be 34.7% among 17,048 adults, increasing to 48.6% among those aged 60 years or older. 12 In another survey of 8814 individuals in the United States, the prevalence of MetS was over 40% among those aged 60–69 years. 13 The prevalence of MetS in the Chinese population is relatively lower compared to populations in developed countries. In a survey of 2975 subjects in China, the prevalence of MetS was found to be 12.6%. 14 A cross-sectional survey conducted in 2001 in 31 Chinese provinces and cities found the standardized prevalence of MetS was 13.7% (9.8% for men and 17.8% for women). 15 It is crucial to find ways to early diagnose patients at high risk for MetS, all -Abstract Truncated-

A Nine-Hub-gene Signature of Metabolic Syndrome Identified Using Machine Learning Algorithms and Integrated Bioinformatics

Identification of Novel Biomarkers for Metabolic Syndrome Based on Machine Learning Algorithms and Integrated Bioinformatics Analysis

Identification of diagnostic genes for both Alzheimer's disease and Metabolic syndrome by the machine learning algorithm

Identification of new co-diagnostic genes for sepsis and metabolic syndrome using single-cell data analysis and machine learning algorithms

Identification and verification of immune-related genes for diagnosing the progression of atherosclerosis and metabolic syndrome

An Augmented Model with Inferred Blood Features for the Self-diagnosis of Metabolic Syndrome.

MicroRNA Expression Profile and Identification of Novel Microrna Biomarkers for Metabolic Syndrome

Identification Of Potential Biomarkers For Risk Analysis Of Colorectal Cancer Using A Combined Bioinformatics Analysis

Identification of Metabolic Syndrome-Related miRNA-mRNA Regulatory Networks and Key Genes Based on Bioinformatics Analysis

Plasma Metabolic Fingerprints for Large-Scale Screening and Personalized Risk Stratification of Metabolic Syndrome

Machine learning-aided risk prediction for metabolic syndrome based on 3 years study

Identification of Crucial Genes for Predicting the Risk of Atherosclerosis with System Lupus Erythematosus Based on Comprehensive Bioinformatics Analysis and Machine Learning

Identifying of immune‐associated genes for assessing the obesity‐associated risk to the offspring in maternal obesity: A bioinformatics and machine learning

The shared biomarkers and pathways of systemic lupus erythematosus and metabolic syndrome analyzed by bioinformatics combining machine learning algorithm and single-cell sequencing analysis

Identification of immune-associated genes in diagnosing osteoarthritis with metabolic syndrome by integrated bioinformatics analysis and machine learning

Multi-stage metabolomics and genetic analyses identified metabolite biomarkers of metabolic syndrome and their genetic determinants

Identification of diagnostic genes and drug prediction in metabolic syndrome-associated rheumatoid arthritis by integrated bioinformatics analysis, machine learning, and molecular docking

Machine Learning-Based Metabolic Syndrome Identification

Machine Learning-Driven Metabolic Syndrome Prediction: An International Cohort Validation Study

Identifying Metabolic Syndrome Easily and Cost Effectively Using Non-Invasive Methods with Machine Learning Models

A comprehensive multi-task deep learning approach for predicting metabolic syndrome with genetic, nutritional, and clinical data